With the progression of clinical trials, sponsors are increasingly turning to contract research organizations (CROs) for their specialized expertise in efficient and resourceful allocation. Nonetheless,
The prevalence of Crohn’s Disease (CD) is on the rise, impacting almost 500,000 people in America alone. CD falls under the category of Inflammatory Bowel
During the startup phase, around 75% of clinical trials are expected to face a one-month delay. This postponement can lead to losses ranging from US$600,000
Skin disease affects 25% of Americans and ranks as the 18th greatest cause of Disability Adjusted Life Years (DALY) globally. This places a heavy burden
Biopharmaceutical companies seek the help of contract research organizations (CROs) to help them navigate the intricate terrain of drug development and regulatory pathways to introduce
VISIT US
ECLEVAR FRANCE:
231 rue Saint-Honoré, 75001 Paris, France
ECLEVAR GMBH
ERFURT, Erfurt Hauptbahnhof
4th, 5th floor
Bahnhofstr. 38 Erfurt 99084
ECLEVAR Australia
Umina Beach NSW 2257, Australia
ECLEVAR UK Limited
3rd Floor 207 Regent Street, London, W1B 3HH
CONTACT US
